Literature DB >> 19246475

Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension.

Yu-Ming Kang1, Ying Ma, Jin-Ping Zheng, Carrie Elks, Srinivas Sriramula, Zhi-Ming Yang, Joseph Francis.   

Abstract

AIMS: Angiotensin II (ANG II)-induced inflammatory and oxidative stress responses contribute to the pathogenesis of hypertension. In this study, we determined whether nuclear factor-kappa B (NF-kappaB) activation in the hypothalamic paraventricular nucleus (PVN) increases oxidative stress and contributes to the ANG II-induced hypertensive response. METHODS AND
RESULTS: Rats were infused intravenously with ANG II (10 ng/kg per min) or saline for 4 weeks. These rats received either vehicle or losartan (LOS, 20 microg/h), an angiotensin II type 1 receptor (AT1-R) antagonist; pyrrolidine dithiocarbamate (PDTC, 5 microg/h), a NF-kappaB inhibitor; tempol (TEMP, 80 microg/h), a superoxide scavenger; LOS (20 microg/h), and PDTC (5 microg/h); or TEMP (80 microg/h) and PDTC (5 microg/h), given intracerebroventricularly (ICV) via osmotic minipump. ANG II infusion resulted in increased mean arterial pressure, renal sympathetic nerve activity, plasma proinflammatory cytokines (PIC), norepinephrine, and aldosterone. These rats also had higher levels of Fra-LI (an indicator of chronic neuronal activation), PIC, phosphorylated IKKbeta, NF-kappaB subunits, AT1-R, superoxide, and gp91phox (a subunit of NADP(H) oxidase) and lower levels of IkappaBalpha in the PVN than control animals. ICV treatment with LOS, PDTC, or TEMP attenuated these changes, and combined treatment with ICV LOS and PDTC, or ICV TEMP and PDTC prevented these ANG II-induced hypertensive responses.
CONCLUSION: These findings suggest that an ANG II-induced increase in the brain renin-angiotensin system activates NF-kappaB in the PVN and contributes to sympathoexcitation in hypertension. The increased superoxide in the PVN contributes to NF-kappaB activation and neurohumoral excitation in hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246475      PMCID: PMC2682616          DOI: 10.1093/cvr/cvp073

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  36 in total

1.  Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension.

Authors:  Megumi Fujita; Katsuyuki Ando; Ai Nagae; Toshiro Fujita
Journal:  Hypertension       Date:  2007-06-18       Impact factor: 10.190

2.  An emerging role for inflammatory cytokines in hypertension.

Authors:  Joey P Granger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-03       Impact factor: 4.733

3.  Regulation of vascular type 1 angiotensin receptors by cytokines.

Authors:  H Sasamura; Y Nakazato; T Hayashida; Y Kitamura; M Hayashi; T Saruta
Journal:  Hypertension       Date:  1997-07       Impact factor: 10.190

4.  Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure.

Authors:  Yu-Ming Kang; Zhi-Hua Zhang; Ralph F Johnson; Yang Yu; Terry Beltz; Alan Kim Johnson; Robert M Weiss; Robert B Felder
Journal:  Circ Res       Date:  2006-09-07       Impact factor: 17.367

5.  Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4.

Authors:  Jian-Mei Li; Lampson M Fan; Michael R Christie; Ajay M Shah
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Endogenous ANG II supports lumbar sympathetic activity in conscious sodium-deprived rats: role of area postrema.

Authors:  L Xu; J P Collister; J W Osborn; V L Brooks
Journal:  Am J Physiol       Date:  1998-07

7.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Authors:  S Rajagopalan; S Kurz; T Münzel; M Tarpey; B A Freeman; K K Griendling; D G Harrison
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

8.  Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension.

Authors:  S Cottone; A Vadalà; M C Vella; E Nardi; G Mulé; A Contorno; R Riccobene; G Cerasola
Journal:  Am J Hypertens       Date:  1998-05       Impact factor: 2.689

9.  TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats.

Authors:  Anuradha Guggilam; Masudul Haque; Edmund Kenneth Kerut; Elizabeth McIlwain; Pamela Lucchesi; Inder Seghal; Joseph Francis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-06       Impact factor: 4.733

10.  The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.

Authors:  Z W Li; W Chu; Y Hu; M Delhase; T Deerinck; M Ellisman; R Johnson; M Karin
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  101 in total

Review 1.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

Review 3.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

4.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

5.  Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure.

Authors:  Yu-Ming Kang; Ai-Qun Zhang; Xiu-Fang Zhao; Jeffrey P Cardinale; Carrie Elks; Xi-Mei Cao; Zhen-Wen Zhang; Joseph Francis
Journal:  Basic Res Cardiol       Date:  2011-02-02       Impact factor: 17.165

6.  TNF-α receptor 1 knockdown in the subfornical organ ameliorates sympathetic excitation and cardiac hemodynamics in heart failure rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

Review 7.  Brain cytokines as neuromodulators in cardiovascular control.

Authors:  Peng Shi; Mohan K Raizada; Colin Sumners
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

Review 8.  Neuroinflammatory basis of metabolic syndrome.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Mol Metab       Date:  2013-10-05       Impact factor: 7.422

Review 9.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 10.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.